期刊文献+

S100A8基因在喉鳞癌发生中作用机制的研究 被引量:2

The molecular mechanism of S100A8 gene in the pathogenesis of laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的:研究S100A8与喉癌发生的关系,揭示炎症在喉癌发生中的作用。方法:应用RT-PCR、Western Blot、免疫组化检测S100A8表达,RNAi方法检测其功能、Transwell检测细胞侵袭力,TUNEL和流式细胞仪检测细胞凋亡,MTT检测细胞生长活性。结果:36例喉鳞癌组织中17例出现S100A8 mRNA表达上调(47.2%),而7例喉部良性肿瘤中2例出现表达上调(28.5%)。13例病人喉鳞癌组织中7例S100A8蛋白表达增高。免疫组化分析喉鳞癌组织S100A8蛋白阳性率为54.3%。在高分化喉鳞癌组织为71.4%,而分化程度差的喉癌组织中阳性率为12.8%(P=0.023)。RNAi抑制S100A8基因使Hep2细胞凋亡率增高近9倍,使Hep2细胞侵袭力下降,影响Bcl-2基因表达,但对Hep2细胞的IKKα表达无明显影响。结论:S100A8与喉鳞癌发生相关并参与喉鳞癌分化,S100A8基因具有抑制喉癌细胞凋亡,促进Hep2细胞侵袭的作用。S100A8基因可能部分通过NF-κB通路参与喉癌发生、发展,在此通路中S100A8基因位于p65下游。 Objective:S100A8 (MRP8) ,deregulated in many other cancers,was found deregulation in laryngeal squamous cell carcinoma (LSCC) in our previous cDNA microarray. The present study is to explore the effect of S100A8 gene on the pathogenesis of LSCCs. Methods: Semiquantitative RT- PCR,immunohistochemical and Western blot were used to analyze expression of S100A8. RNA interference (RNAi) inhibited expression of mRNA to evaluate the gene function , TUNEL and Flow cytometer assay detected cell apoptosis, MTT assays cell proliferation. Results: S100A8 mRNA in 47.2% of LSCCs(17/36) were up - regulated compared to PANLs,but only 28.5% of benign tumors up -regulated (2/7). S100A8 protein were up - regulated in 7 of 13 LSCCs. The positively stained frequencies of S100A8 in well,moderately and poorly - differentiated LSCCs were 71.4% ,53.8% and 12.5% ,respectively ( P = 0. 023, P = 0.14 ). The rates of apoptosis of Hep2 cells after SI00A8 RNAi, reached to 17.32% , which enhanced nearly 9 - fold, and the invasion was inhibited, but had less effect on Hep2 cells proliferation. S100A8 RNAi affected the expression of BCL- 2 genes, but had no effects on p65, RELB, IKKa and IKKB genes, however,p65 RNAi showed down -regulation of S100A8 mRNA. Conclusion: S100A8 gene involved in the pathogenesis of LSCCs and regulated apoptosis and enhanced invasion of Hep2 cells. S100A8 gene may be related and interacted between NF -kB pathyway in laryngeal carcinoma.
出处 《现代肿瘤医学》 CAS 2010年第6期1090-1093,共4页 Journal of Modern Oncology
基金 国家自然科学基金项目(编号:30171008)
关键词 喉鳞状细胞癌 S100A8基因 RNA干涉 NF-ΚB通路 laryngeal squamous cell carcinoma ( LSCC ) SIOOA8 gene RNAi NF - KSB pathyway
  • 相关文献

参考文献20

  • 1李连弟,饶克勤,张思维,鲁凤珠,邹小农.中国12市县1993年~1997年肿瘤发病和死亡登记资料统计分析[J].中国肿瘤,2002,11(9):497-507. 被引量:193
  • 2Kerkhoff C,Klempt M,Sorg C.Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)[J].Bio-chim Biophys Acta,1998,1448:200-211.
  • 3Zhi H,Zhang J,Hu G,et al.The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell car-cinoma[J].Int J Cancer,2003,106(3):327-333.
  • 4Stulik J,Osterreicher J,Koupilova K,et al.The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma; the S100A9 and S100A8 positive cells underlie and invade tumor mass[J].Electrophoresis,1999,20(4-5):1047-1054.
  • 5Yui S,Nakatni Y,Mikami M.Calprotectin (S100A8/S100A9),an inflammatory protein complex from neutrophils with a broad apopto-sis-inducing activity[J].Biol Pharm Bull,2003,26(6):753-760.
  • 6Chaurand P,DaGue BB,Peaisall RS,et al.Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry[J].Proteomics,2001,1:1320-1326.
  • 7Helmut W Ott,Herbert Lindner.Calgranulins in cystic fluid and serum from patients with ovarian carcinomas[J].Cancer Res,2003,63:7507-7514.
  • 8Gebbardt C,Breitenbach U,Turkennann P,et al.Calgranulins S100A8 and S100A9 are negtively regulated by glucocoirticoid in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis[J].Oncogene,2002,21:4266-4276.
  • 9Stulik J,Osterreicher J,Koupilova K,et al.The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. the S100A9 and S100A8 positive cells underlie and invade tumor mass[J].Electrophoresis,1999,20(4-5):1047-1054.
  • 10Wilkinson MM,Busuttil A,Haywrd C,et al.Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues[J].J Cell Sci,1988,91(Pl 2):221-230.

共引文献192

同被引文献23

  • 1Garcia-Lora A, Algarra I, CoUado A, ct al. Turnout immunology, vaccination and escape strategies [ J ]. Eur J Immunogenet, 2003, 30(3 ) : 177-183.
  • 2Klug F, Miller M, Schmidt HH, et al. Characterization of MHC ligands for peptide based tumor vaccination [ J ]. Curt Pharm Des, 2009,15(28) :3221-3236.
  • 3Cabrera T, Maleno I, Lopez-Nevot MA, et al. High frequency of HLA-B44 allelic loases in human solid tumors [J]. Hum Immunol, 2003,64(10) :941-950.
  • 4Cabrera T, Salinero J, Fernandez MA, et al. High frequency of altered HLA chLss I phenotypes in laryngeal carcinomas [ J ]. Hum Immunol, 2000,61 (5) :499-506.
  • 5Ogoshi K, Tajima T, Mitomi T, et al. HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer [J]. Clin Exp Metastasis, 1996,14(3) :277-281.
  • 6Cabrera T, Angustias-Fernandez M, Sierra A, et al. High frequency of altered HLA class I phenotypes in invasive breast carcinomas [J]. Hum Immunol, 1996,50(2) :127-134.
  • 7Puppo F, Contini P, Ghio M, et al. Soluble HLA class I molecules/ CDs ligation trigger apoptosis of CDs+ cells by Fas/Fas-ligand interaction [J]. Scientific World Journal, 2002, (2) :421-423.
  • 8Klug F, Miller M, Schmidt H H, et al. Characterization of MHC ligands for peptide based tumor vaccination[J]. Curr Pharm Des, 2009, 15(28): 3221-3236.
  • 9Bedikian A Y, Del Vecchio M. Allovectin-7 therapy in metastat ic melanoma[J]. Expert Opin Biol Ther, 2008, 8(6):839-844.
  • 10Iwahashi M, Katsuda M, Nakamori M, et al. Vaccination with peptides derived from cancer-testis antigens in combination with CPG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma[J]. Cancer Sei, 2010, 101(12):2510-2517.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部